Cargando…
Clinician-Patient Dialogue About Preventive Chronic Migraine Treatment
Many new medications for the treatment of migraine are now available on the market. In the current evolving migraine treatment landscape, an individualized treatment approach is needed. This review provides practical recommendations on how to obtain a correct diagnosis and then engage in a long-term...
Autor principal: | Blumenfeld, Andrew M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536484/ https://www.ncbi.nlm.nih.gov/pubmed/32988278 http://dx.doi.org/10.1177/2150132720959935 |
Ejemplares similares
-
Combination CGRP monoclonal antibody and onabotulinumtoxinA treatment for preventive treatment in chronic migraine
por: Ailani, Jessica, et al.
Publicado: (2021) -
Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine
por: Blumenfeld, Andrew M., et al.
Publicado: (2015) -
Long-term reductions in disease impact in patients with chronic migraine following preventive treatment with eptinezumab
por: Blumenfeld, Andrew, et al.
Publicado: (2022) -
Supposed Dialogue about Temperance
Publicado: (1885) -
Effectiveness and Safety of Chronic Migraine Preventive Treatments: A Systematic Literature Review
por: Blumenfeld, Andrew M., et al.
Publicado: (2022)